Antithrombotic use following transient ischaemic attack or ischaemic stroke among older Australians with atrial fibrillation

Intern Med J. 2014 Nov;44(11):1134-7. doi: 10.1111/imj.12582.


Hospital audits may underestimate anticoagulant use among acute ischaemic stroke patients with atrial fibrillation (AF), as treatment may commence after discharge. To account for this, antithrombotic use in the 4 months after hospitalisation for transient ischaemic attack or ischaemic stroke among AF patients was assessed using claims data. Results suggest that treatment may be commenced soon after discharge and should be considered when assessing prevalence of use.

Keywords: Australia; anticoagulants; atrial fibrillation; brain infarction; transient ischaemic attack.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged, 80 and over
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / epidemiology
  • Australia / epidemiology
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / epidemiology
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Ischemic Attack, Transient / drug therapy*
  • Ischemic Attack, Transient / epidemiology
  • Male
  • Retrospective Studies
  • Risk Factors
  • Stroke / drug therapy*
  • Stroke / epidemiology


  • Fibrinolytic Agents